Farmacia
Faculté
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Biomédica de Salamanca (23)
2024
-
Platelet C3G: a key player in vesicle exocytosis, spreading and clot retraction
Cellular and Molecular Life Sciences, Vol. 81, Núm. 1
2023
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
2022
-
C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process
International journal of biological sciences, Vol. 18, Núm. 15, pp. 5873-5884
-
Environmental drivers of the seasonal exposure to airborne Alternaria spores in Spain
Science of the Total Environment, Vol. 823
-
New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance
Frontiers in Cell and Developmental Biology, Vol. 10
2021
-
C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells
Cell Death and Disease, Vol. 12, Núm. 4
-
C3G protein, a new player in glioblastoma
International Journal of Molecular Sciences, Vol. 22, Núm. 18
-
Compound endoscopic morphological features for identifying non-pedunculated lesions ≥20 mm with intramucosal neoplasia
Cancers, Vol. 13, Núm. 21
-
Contribution of c3g and other gefs to liver cancer development and progression
Hepatoma Research, Vol. 7
-
The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment
Diagnostics, Vol. 11, Núm. 5
2020
-
C3G contributes to platelet activation and aggregation by regulating major signaling pathways
Signal Transduction and Targeted Therapy, Vol. 5, Núm. 1
-
C3G is upregulated in hepatocarcinoma, contributing to tumor growth and progression and to HGF/MET pathway activation
Cancers, Vol. 12, Núm. 8, pp. 1-22
-
Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions
Gastrointestinal Endoscopy, Vol. 91, Núm. 4, pp. 868-878.e3
2019
-
Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps
Gastroenterology, Vol. 156, Núm. 1, pp. 75-87
-
Comparative genomics of the major parasitic worms
Nature Genetics, Vol. 51, Núm. 1, pp. 163-174
2018
-
C3G, through its GEF activity, induces megakaryocytic differentiation and proplatelet formation
Cell Communication and Signaling, Vol. 16, Núm. 1
2017
-
A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts
Leukemia Research, Vol. 56, pp. 82-87
-
C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis
Oncotarget, Vol. 8, Núm. 67, pp. 110994-111011
-
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
Oncotarget, Vol. 8, Núm. 16, pp. 26027-26040